High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-β and tau pathologies in the 3xTg-AD model of Alzheimer's disease

[1]  F. Calon,et al.  High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model , 2010, Neurobiology of Aging.

[2]  Ling Li,et al.  Intake of Sucrose-sweetened Water Induces Insulin Resistance and Exacerbates Memory Deficits and Amyloidosis in a Transgenic Mouse Model of Alzheimer Disease* , 2007, Journal of Biological Chemistry.

[3]  N. Salem,et al.  Whole body distribution of deuterated linoleic and alpha-linolenic acids and their metabolites in the rat. , 2007, Journal of lipid research.

[4]  J. Sawyer,et al.  Dietary Fat–Induced Alterations in Atherosclerosis Are Abolished by ACAT2-Deficiency in ApoB100 Only, LDLr−/− Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[5]  R. Eckel,et al.  Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. , 2007, Circulation.

[6]  Frank M LaFerla,et al.  Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels , 2007, The Journal of Neuroscience.

[7]  J. Manson,et al.  A Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease , 2007, Circulation.

[8]  Richard N Bergman,et al.  Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. , 2007, The American journal of medicine.

[9]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[10]  I. Lemieux,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[11]  M. Goedert,et al.  A Century of Alzheimer's Disease , 2006, Science.

[12]  H. Roche,et al.  Conjugated linoleic acid: a functional nutrient in the different pathophysiological components of the metabolic syndrome? , 2006, Current opinion in clinical nutrition and metabolic care.

[13]  R. Green,et al.  Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. , 2006, Archives of neurology.

[14]  M. Laakso,et al.  Association of metabolic syndrome with Alzheimer disease , 2006, Neurology.

[15]  H. Tanila,et al.  Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice , 2006, Neurobiology of Disease.

[16]  J. Schneider,et al.  Dietary copper and high saturated and trans fat intakes associated with cognitive decline. , 2006, Archives of neurology.

[17]  D. Mozaffarian,et al.  Plasma Phospholipid Trans Fatty Acids, Fatal Ischemic Heart Disease, and Sudden Cardiac Death in Older Adults: The Cardiovascular Health Study , 2006, Circulation.

[18]  K. M. Phillips,et al.  New and existing oils and fats used in products with reduced trans-fatty acid content. , 2006, Journal of the American Dietetic Association.

[19]  A. Aro.  The scientific basis for trans fatty acid regulations-is it sufficient? A European perspective. , 2006, Atherosclerosis. Supplements.

[20]  D. Mozaffarian,et al.  Trans fatty acids and cardiovascular disease. , 2006, The New England journal of medicine.

[21]  P. Zandi,et al.  Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study , 2006, Alzheimer disease and associated disorders.

[22]  T. Jenkins,et al.  Major advances in nutrition: impact on milk composition. , 2006, Journal of dairy science.

[23]  A. Rajput,et al.  Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys , 2006, Neurochemistry International.

[24]  Mark Bowlby,et al.  Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Yaqoob,et al.  Conjugated linoleic acid and human health: a critical evaluation of the evidence , 2006, Current opinion in clinical nutrition and metabolic care.

[26]  Takashi Morihara,et al.  Dietary n‐3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease , 2005, The European journal of neuroscience.

[27]  S. Dey,et al.  Variation in commercial rodent diets induces disparate molecular and physiological changes in the mouse uterus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[29]  Nader Rifai,et al.  Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. , 2005, The Journal of nutrition.

[30]  R. Mensink.  Metabolic and health effects of isomeric fatty acids , 2005, Current opinion in lipidology.

[31]  T. Yajima,et al.  A novel autoregulatory mechanism for transcriptional activation of the IL‐15 gene by a nonsecretable isoform of IL‐15 generated by alternative splicing , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Roger Kurlan,et al.  A focus on the synapse for neuroprotection in Alzheimer disease and other dementias , 2004, Neurology.

[33]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[34]  R S Wilson,et al.  Dietary fat intake and 6-year cognitive change in an older biracial community population , 2004, Neurology.

[35]  Patrick R Hof,et al.  Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  D. Bennett,et al.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. , 2004, Archives of neurology.

[37]  K. Fukuchi,et al.  Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. , 2003, The American journal of pathology.

[38]  Mark P Mattson,et al.  GeneDiet Interactions in Brain Aging and Neurodegenerative Disorders , 2003, Annals of Internal Medicine.

[39]  A. Lichtenstein,et al.  Effect of different forms of dietary hydrogenated fats on LDL particle size. , 2003, The American journal of clinical nutrition.

[40]  F. Pérez-Llamas,et al.  Dietary trans fatty acids alter the compositions of microsomes and mitochondria and the activities of microsome delta6-fatty acid desaturase and glucose-6-phosphatase in livers of pregnant rats. , 2003, The Journal of nutrition.

[41]  Deborah Gustafson,et al.  An 18-year follow-up of overweight and risk of Alzheimer disease. , 2003, Archives of internal medicine.

[42]  R. Mensink,et al.  Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. , 2003, The American journal of clinical nutrition.

[43]  D. Bennett,et al.  Dietary fats and the risk of incident Alzheimer disease. , 2003, Archives of neurology.

[44]  A. Ascherio.  Epidemiologic studies on dietary fats and coronary heart disease. , 2002, The American journal of medicine.

[45]  A. Hofman,et al.  Diet and risk of dementia: Does fat matter? , 2002, Neurology.

[46]  J. Manson,et al.  Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. , 2001, The New England journal of medicine.

[47]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[48]  J. Manson,et al.  Dietary fat intake and risk of type 2 diabetes in women. , 2001, The American journal of clinical nutrition.

[49]  P. Wainwright,et al.  Dietary trans fatty acids combined with a marginal essential fatty acid status during the pre- and postnatal periods do not affect growth or brain fatty acids but may alter behavioral development in B6D2F(2) mice. , 2001, The Journal of nutrition.

[50]  A. Lichtenstein,et al.  Impact of hydrogenated fat on high density lipoprotein subfractions and metabolism. , 2001, Journal of lipid research.

[51]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[52]  M. Girón,et al.  Dietary Trans Fatty Acids Affect Docosahexaenoic Acid Concentrations in Plasma and Liver but not Brain of Pregnant and Fetal Rats , 2000, Pediatric Research.

[53]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[54]  A. Lichtenstein,et al.  Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. , 1999, The New England journal of medicine.

[55]  D. Allison,et al.  Estimated intakes of trans fatty and other fatty acids in the US population. , 1999, Journal of the American Dietetic Association.

[56]  R. Nicolosi,et al.  Effects of specific fatty acids (8:0, 14:0, cis-18:1, trans-18:1) on plasma lipoproteins, early atherogenic potential, and LDL oxidative properties in the hamster. , 1998, Journal of lipid research.

[57]  G A Colditz,et al.  Dietary fat intake and the risk of coronary heart disease in women. , 1997, The New England journal of medicine.

[58]  M. Jauhiainen,et al.  Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. , 1997, The American journal of clinical nutrition.

[59]  J. I. Pedersen,et al.  Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. , 1995, Journal of lipid research.

[60]  M. Piciotti,et al.  Incorporation oftrans long-chain n−3 polyunsaturated fatty acids in rat brain structures and retina , 1994, Lipids.

[61]  J. Wittes,et al.  Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. , 1994, The American journal of clinical nutrition.

[62]  J. Opstvedt,et al.  trans fatty acids, 5. Fatty acid composition of lipids of the brain and other organs in suckling piglets , 1992, Lipids.

[63]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[64]  R. Mensink,et al.  Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. , 1990, The New England journal of medicine.

[65]  E. G. Hill,et al.  Perturbation of the metabolism of essential fatty acids by dietary partially hydrogenated vegetable oil. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[66]  P. Parodi.  Distribution of isomeric octadecenoic fatty acids in milk fat. , 1976, Journal of dairy science.

[67]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[68]  Jun Wang,et al.  Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications. , 2007, Interdisciplinary topics in gerontology.

[69]  D. Bennett,et al.  Biochemical Characterization of Aβ and Tau Pathologies in Mild Cognitive Impairment and Alzheimer's Disease , 2007 .

[70]  G. Wilcock,et al.  The metabolic syndrome and Alzheimer disease. , 2007, Archives of neurology.

[71]  R. Nicolosi,et al.  Trans fatty acids and cardiovascular risk. , 2001, The journal of nutrition, health & aging.

[72]  A. Kafatos,et al.  Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study , 2000, European Journal of Clinical Nutrition.

[73]  R. Mensink,et al.  Trans fatty acids and their effects on lipoproteins in humans. , 1995, Annual review of nutrition.